Portal de investigación
Medicina personalizada en pacientes con cáncer colorrectal localizado: abordaje multiómico de la Enfermedad Mínima Residual en biopsia líquida y modelos de organoides
Datos básicos
- Protocolo:
- PI18/01909
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL CLINICO UNIVERSITARIO DE VALENCIA
- Año de incio:
- 2019
- Año de finalización:
- 2021
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
Resultados del Ensayo Clínico
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction"
Papaccio, Federica; (...); Castillo, Josefa
Article. 10.1186/s13046-022-02591-z. 2023
Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer.
Smyth, Elizabeth C, Cervantes, Andres
Editorial Material. 10.1136/esmoopen-2020-001107. 2020
BISPECIFIC ANTIBODIES INCREASE THE THERAPEUTIC WINDOW OF CD40 AGONISTS THROUGH SELECTIVE DENDRITIC CELL TARGETING
Ciardiello, D; (...); Cervantes, A
News Item. 2022
Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review.
Huerta, Marisol; (...); Ibarrola-Villava, Maider
Article. 10.3390/cancers13050994. 2021
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences.
Henriksen, Tenna Vesterman; (...); Andersen, Claus Lindbjerg
Article. 10.1158/1078-0432.CCR-21-2404. 2022
Clinical management of metastatic colorectal cancer in the era of precision medicine.
Ciardiello, F; (...); Cervantes, A
Article. 10.3322/caac.21728. 2022
Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer.
Gimeno-Valiente, F; (...); Castillo, J
Article. 10.3390/cancers13061433. 2021
Improving tumor budding evaluation in colon cancer by extending the assessment area in colectomy specimen.
Martinez-Ciarpaglini, Carolina; (...); Cervantes, Andres
Article. 10.1111/his.13900. 2019
In the literature: April 2020
Gambardella, V; (...); Cervantes, A
Editorial Material. 10.1136/esmoopen-2020-000749. 2020
In the literature: April 2021.
Martin-Martorell, P; (...); Cervantes, A
News Item. 10.1016/j.esmoop.2021.100116. 2021
In the literature: April 2022.
Ciardiello, D; (...); Cervantes, A
Editorial Material. 10.1016/j.esmoop.2022.100479. 2022
In the literature: August 2020.
Gambardella, Valentina; (...); Cervantes, Andres
Article. 10.1136/esmoopen-2020-000909. 2020
In the literature: December 2019
Gambardella, V; (...); Cervantes, A
Editorial Material. 10.1136/esmoopen-2019-000642. 2020
In the literature: December 2020.
Gambardella, V; (...); Cervantes, A
News Item. 10.1016/j.esmoop.2020.100009. 2021
In the literature: December 2021.
Montagut C; (...); Cervantes A
News Item. 10.1016/j.esmoop.2021.100352. 2022
In the literature: February 2020
Roda, D; (...); Cervantes, A
Editorial Material. 10.1136/esmoopen-2020-000680. 2020
In the literature: February 2021
Cejalvo, JM; (...); Cervantes, A
News Item. 10.1016/j.esmoop.2021.100061. 2021
In the literature: February 2022.
Gambardella, V; (...); Cervantes, A
Editorial Material. 10.1016/j.esmoop.2022.100411. 2022
In the literature: June 2020.
Roda, Desamparados; (...); Cervantes, Andres
Article. 10.1136/esmoopen-2020-000832. 2020
In the literature: June 2021.
Gambardella, V; (...); Cervantes, A
News Item. 10.1016/j.esmoop.2021.100186. 2021
In the literature: October 2020.
Gambardella, Valentina; (...); Cervantes, Andres
Article. 10.1136/esmoopen-2020-001048. 2020
In the literature: October 2021.
Gambardella, V; (...); Cervantes, A
News Item. 10.1016/j.esmoop.2021.100285. 2021
Integrative immune transcriptomic classification could improve patient selection for precision immunotherapy in advanced gastroesophageal adenocarcinoma
Segura, MC; (...); Fleitas, TC
Meeting Abstract. 10.1016/j.annonc.2022.09.065. 2022
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study.
Gambardella, Valentina; (...); Roda, Desamparados
Article. 10.1038/s41416-021-01502-x. 2021
MULTIOMIC PROFILING OF CHECKPOINT INHIBITOR-TREATED MELANOMA: IDENTIFYING PREDICTORS OF RESPONSE AND RESISTANCE AS WELL AS MARKERS OF BIOLOGICAL DISCORDANCE
Gambardella, V; (...); Cervantes, A
News Item. 2022
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer.
Papaccio, Federica; (...); Cervantes, Andres
Article. 10.3390/cancers12123611. 2020
New Guidelines for optimal patient care with localized colon cancer: recommending what is proven, but also watching what research is bringing.
Tarazona, Noelia; (...); Cervantes, Andres
Editorial Material. 10.1016/j.annonc.2020.07.012. 2020
NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2 -Amplified Gastric Cancer.
Gambardella, V; (...); Cervantes, A
Article. 10.1158/1078-0432.CCR-18-2421. 2019
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress.
Gambardella, Valentina; (...); Cervantes, Andres
Article. 10.3390/jcm9093049. 2020
Reply to the letter to the editor: adjuvant nivolumab for the management of the pathological residual disease in esophageal or junctional tumors: a word of caution by PK Garg, R. Kumar and P. Dixit
Smyth, E C; (...); Fleitas, T
Letter. 10.1016/j.annonc.2021.05.795. 2021
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
Tarazona, N; (...); Cervantes, A
Article. 10.1093/annonc/mdz390. 2019
The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
Gambardella, V; (...); Fleitas, T
Article. 10.1016/j.ctrv.2020.102015. 2020
Towards precision oncology for anti-HER2 blockade in gastroesophageal adenocarcinoma.
Gambardella, V; (...); Cervantes, A
Review. 10.1093/annonc/mdz143. 2019
Understanding mechanisms of primary resistance to checkpoint inhibitors will lead to precision immunotherapy of advanced gastric cancer
Gambardella, V, Fleitas, T, Cervantes, A
Editorial Material. 10.1093/annonc/mdz008. 2019
Understanding the clinical behavior of relapsed colon cancers with microsatellite instability relative to BRAF mutations.
Roda, D, Rosello, S, Cervantes, A
Editorial Material. 10.1093/annonc/mdz229. 2019
Will Organoids Fill the Gap towards Functional Precision Medicine?
Papaccio, Federica; (...); Cervantes, Andres
Article. 10.3390/jpm12111939. 2022
